DSCI
Derma Sciences, Inc.
Set alert
- Open
- 7.00
- Prev close
- 7.00
- Mkt cap
- 0
- Vol
- 57.50K
- Avg vol
- 149.72K
- EPS
- -347.22
- P/E
- -0.02
More statistics
- Low
- 6.96
- High
- 7.05
- Earnings
- Mar 15, 2017
News
9 years ago businesswire.com
Derma Sciences Reports 2016 Third Quarter Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
10 years ago businesswire.com
Derma Sciences Reports 2016 Second Quarter Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
10 years ago businesswire.com
Derma Sciences to Acquire BioD, Solidify Its Leadership Position in Advanced Wound Care and Regenerative Products
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announces the signing of a definitive agreement to acquire…
10 years ago businesswire.com
Derma Sciences Reports 2016 First Quarter Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
10 years ago businesswire.com
Derma Sciences Reports 2015 Fourth Quarter and Full Year Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
10 years ago businesswire.com
Derma Sciences to Hold Conference Call on November 12 to Discuss Data Monitoring Committee Pre-Specified Interim Analysis of the Aclerastide Phase 3 Trials
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, will issue a news release at 7:30 a.m. Eastern time on…
10 years ago businesswire.com
Derma Sciences Reports Third Quarter 2015 Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
11 years ago businesswire.com
CORRECTING and REPLACING Derma Sciences Reports Second Quarter Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--In the Management Commentary section, fifth graph, last sentence should read: We continue to expect full-year sales of $43.8 million for the TWC business in 2015,”…
11 years ago businesswire.com
Derma Sciences Reports First Quarter 2015 Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
11 years ago businesswire.com
Derma Sciences Reports Fourth Quarter and Year Ended Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
11 years ago businesswire.com
Derma Sciences Reports Third Quarter Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
12 years ago businesswire.com
Derma Sciences Reports Second Quarter Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
12 years ago businesswire.com
Derma Sciences Reports First Quarter Financial Results
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the…
12 years ago businesswire.com
Derma Sciences Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion and Progress in Launching New Placental-Derived Tissue Products
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (the “Company”) (Nasdaq:DSCI), a tissue regeneration and burn care company focused on advanced wound care, today reported financial and…